1Klebanoff SJ.Myeloperoxidase:friend and foe[J].J Leukoc Biol,2005,77(5):598-625.
2Stocker R,Keaney JF Jr.Role of oxidative modifications in atherosclerosis[J].Physiol Bey,2004,84(4):1381-1478.
3Armstrong EJ,Morrow DA,Sabatine MS.Inflammatory biomarkers in acute coronary syndromes:part Ⅲ:biomarkers of oxidative stress and angiogenic growth factors[J].Circulation,2006,113(8):e289-292.
4Madamanchi NR,Tchivilev I,Runge M.Genetic markers of oxidative stress and coronary atherosclerosis[J].Curr Atheroscler Rep,2006,8(3):177-183.
5Nicholls SJ,Hazen SL.Myeloperoxidase and cardiovascular disease[J].Arterioscler Thromb Vasc Biol,2005,25(6):1102-1111.
6Kawamura M,Heinecke JW,Chair A.Increased uptake of alpha-hydroxy aldehyde-modified low density lipoprotein by macrophage scavenger receptors[J].J Lipid Res,2000,41(7):1054-1059.
7Daugherty A,Dunn JL Rateri DL et al.Myeloperoxidase,a catalyst for lipoprotein oxidation,is expressed in human atherosclerotic lesions[J].J Clin Invest,1994,94(1):437-444.
8Marsche G,Hammer A,Oskolkova O,et al.Hypochloritemodified high density lipoprotein,a high affinity lignnd to scavenger receptor class B,type Ⅰ,impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport[J].J Biol Chem,2002,277(35):32172-32179.
9Zheng L,Settle M,Brubaker G,et al.Localization of nitration and chlorination sites on apolipoprotein A-Ⅰ catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCAl-dependent cholesterol efflux from macrophages[J].J Biol Chem,2005,280(1):38-47.
10Marsche G,Heller R,Fauler G,et al.2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis[J].Arterioscler Thromb Vasc Biol,2004,24(12):2302-2306.
4Patel PJ,Khera AV,Jafri K. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease[J].Journal of the American College of Cardiology,2011,(20):2068-2075.
5Ansell BJ,Watson KE,Fogelman AM. High-density lipoprotein function recent advances[J].Journal of the American College of Cardiology,2005,(10):1792-1798.doi:10.1016/j.jacc.2005.06.080.
6Lehrke M,Millington SC,Lefterova M. CXCL16 is a marker of inflammation,atherosclerosis,and acute coronary syndromes in humans[J].Journal of the American College of Cardiology,2007,(04):442-449.
7Karlsson H,Leanderson P,Tagesson C. Lipoproteomics Ⅱ:mapping of proteins in high-density lipoprotein using twodimensional gel electrophoresis and mass spectrometry[J].Proteomics,2005,(05):1431-1445.
8Farid AS,Nakahara K,Murakami N. Decreased serum paraoxonase-1 activity during intestinal nematode(Nippostrongylus brasiliensis)infection in rats[J].American Journal of Tropical Medicine and Hygiene,2008,(05):770-776.
9Nourooz-Zadeh J,Tajaddini-Sarmadi J,Wolff SP. Measurement of plasma hydroperoxide concentrations by the ferrous oxidationoxylenol orange assay in conjunction with triphenylphosphin[J].Analytical Biochemistry,1994,(02):403-409.
10Ansell BJ,Navab M,Hama S. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than highdensity lipoprotein cholesterol levels and are favorably affected by simvastatin treatment[J].Circulation,2003,(22):P2751-P2756.
